Riskpilot← Back to searchSign inGet full accessMPLU Biorefining Aps
APSActiveCVR 38814419Langs Hegnet 18BActivities of holding companies · NACE 6421Est. 2017— employees
Revenue 2024
DKK -17K
-121% vs 2023
EBITDA margin
100.0%
-121% vs 2023
Equity ratio
48.7%
Financial strength
Net profit 2024
DKK -26K
-146% vs 2023
| Revenue | DKK -17K | -121% |
| EBITDA | DKK -17K | -121% |
| Net profit | DKK -26K | -146% |
| Total assets | DKK 641K | -6% |
| Equity | DKK 312K | -8% |
| Employees | — | — |
Legal name
MPLU Biorefining Aps
CVR number
38814419
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
25. juli 2017
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktionen
Company purpose
Selskabets formål er 1) at drive virksomhed ved, at det ejer aktier eller anparter i andre selskaber, dvs. andre anpartsselskaber, iværksætterselskaber eller aktieselskaber, og herved forbundet virksomhed, og 2) at drive konsulentvirksomhed samt aktiviteter i tilknytning hertil.
Address
Langs Hegnet 18B
Phone
+4530531713
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 85 | 281 | 0 | -25 | 81 | -17 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -1 | 81 | 281 | -3 | -25 | 81 | -17 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -1 | 81 | 281 | -3 | -25 | 81 | -17 |
| Net financials | -2 | -2 | -2 | -3 | -1 | -13 | -9 |
| Profit before tax | -4 | 79 | 278 | -6 | -26 | 68 | -26 |
| Tax | -0 | 17 | 61 | -0 | 0 | 11 | 0 |
| Net profit | -4 | 61 | 217 | -6 | -27 | 57 | -26 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 129 | 214 | 288 | 423 | 452 | 684 | 641 |
| Equity | 6 | 71 | 227 | 293 | 281 | 338 | 312 |
| Long-term debt | 0 | 0 | 0 | 130 | 161 | 310 | 319 |
| Short-term debt | 122 | 142 | 61 | -0 | 10 | 36 | 10 |
| Total debt | 122 | 142 | 61 | 129 | 171 | 345 | 329 |
EBITDA margin
-1661700.0%
This company
15.8%
Market median
-10517189% vs market
20182024
Equity ratio
48.7%
This company
38.2%
Market median
+27% vs market
20182024
Return on equity
-8.4%
This company
18.4%
Market median
-146% vs market
20182024
Net profit margin
-2610400.0%
This company
8.1%
Market median
-32227260% vs market
20182024
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
20182024
Debt / equity
1.05×
This company
0.62×
Market median
-69% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-07-25 – 2018-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50.0% | 50.0% | 2017 | |
| Individual | 50.0% | 50.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MPLU Biorefining Aps 
Protein Frontiers ApSBoard members of MPLU Biorefining Aps also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|